References
1 Bata BM, Hodge DO, Mohney BG: Neurofibromatosis Type 1: a
population-based population study. J Pediatric Ophthalmol Strabismus
2019;56:243-247
2 National Institute of Health Consensus Development Conference
Statement. Neurofibromatosis. Bethesda, Md, USA, July, 1987.
Neurofibromatosis 1988;1(3):172-178
3 Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J,
Robertson M, Dunn D, Gesteland R, O’Connell P, White R, Bader JL, Miller
RW, Birnboim HC, Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG,
Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL,
Murphree AL, Strong LC, White RL, Cawthon RM, O’Connell P, Buchberg AM,
et al: A major segment of the neurofibromatosis type 1 gene: cDNA
sequence, genomic structure, and point mutations. Cell.
1990;62:193–201.
4 De Castro IJ, Soares da Silva EB, dos santos TR et al: T-cell lymphoma
in a patients with neurofibromatosis type 1 and AIDS. Case Rep Oncol
2017;10:161-168
5 Isa SF, Silas A, Daniyam C et al: An HIV-1 infected patient with
neurofibromatosis type 1: a case report. The Nigerian Health Journal
2012;12:52-54
6 Hiesgen J, Variava E: Neuroendocrine tumult in a patients with
neurofibromatosis type 1 and HIV. S Afr J HIV Med 2015;16(1), Art.
#323, 4 pages
7 Forte D, Nabais A, Pontinha C et al: Simultaneous supratentorial and
infratentorial pilocytic astrocytoma in an adult patients with
concurrent neurofibromatosis type 1 and HIV infection. World Neurosurg
2018;117:172-177
8 Scoot PV, Dreesen JCFM, Cooen E et al: Preimplantation gets testing
for more that one genetic conditions. Hum Reprod 2019;34:1146-1154 al
2019
9 Floridia M, Masuelli G, Meloni A, Cetin A, Tamburini E, Cavalieri AF,
Danzero S et al; Italian Group on Surveillance on Antiretroviral
Treatment in Pregnancy. BJOG 2017;124:1218-1223
10 Eppes C: Low risk of HIV transmission for women on combined
antiretroviral therapy. BJOG 2017;124:1224
11 Gruber A, Pacault M. El Khatatri EP et al: Non-invasive prenatal
diagnosis of paternally inherited disorders from maternal plasma:
detection of NF1 and CTFR mutation using droplet digital PCR. Clin Chem
Lab Med 2018;56:728-738
12 Farhi D, Bastuji-G arin S, Khosrotehrani K et al: Neurofibromatosis
1: analysis of the demand for prenatal diagnosis in a French cohort of
361 patients. Am J Med Genet A 2008;146(A):159-165
13 Terzi YK, Oguzkan-Balci S, Anlar B ET Al: Reproductive decisions
after prenatal diagnosis in neurofibromatosis type 1: importance of
genetic counseling. Genet Couns. 2009;20:195-202.
14 Terry AR, Merker VL, Barker FG 2nd et al: Pregnancy complications in
woman with rare tumor suppressor syndromes affecting central and
peripheral nervous system. Am J Obstet Gynecol. 2015;
213(1) :108-9.
15 Leppävirta, J, Kallionpää, RA, Uusitalo, E, et al. The pregnancy in
neurofibromatosis 1: A retrospective register‐based total population
study. Am J Med Genet Part
A . 2017; 173A: 2641 2648. https://doi.org/10.1002/ajmg.a.38372
16 Walther MM, Herring J, Enquist E et al: von Reckinghausen’s disease
and pheochromocytomas. J Urol 1999;162:1582-1586
17 Leppävirta, Jussi et al. “Congenital anomalies in neurofibromatosis
1: a retrospective register-based total population study.” Orphanet
journal of rare diseases vol. 13,1 5. 15 Jan. 2018,
doi:10.1186/s13023-017-0756-4
18 Peters H, Francis K, Harding K, Tookey PA, Thorne C: Operative
vaginal delivery and invasive procedures in pregnancy among women living
with HIV. Eur J Obstet Gynecol Reprod Biol 2017;201:295-299
19 ThakKar SD, Feigen U, Mautner VF: Spinal tumours in neurofibromatosis
type 1: an MRI study of frequency multiply and variety. Neuroradiology
1999;41:625-629
20 Spiegel JE, Hapgood A, Hess PE: Epidural anesthesia in a parturient
with neurofibromatosis type 2. Int J Ostet Anesth 2005;14:336-339
21 Gaiser R: Low complication rate associated with cesarean section
under spinal anesthesia for HIV- infected women on antiretroviral
therapy. Survey of Anesthesiology 2003;47: 215
22 Benton S, Reese A: HIV and the obstetric patient: anesthetic
considerations. The Internet Journal of Anes thesiology 2009; Volume 24
Number 1 pages 1-7
23 Grownwald C, Vowinkel T, Hahnenkamp K: Regional anesthetic procedures
in immunosuppressed patients: risk of infection. Current Opinion
Anesthesiology 2011;24:698-704
24 Korf BR: Malignancy in neurofibromatosis type 1. Oncologists
2000;5:477-485
25 Schmutz JL: Dermatologic disease influenced by pregnancy (French)
Presse Med 2003;32:1809-1812
26 Nebesio TD, Ming W, Chen S et al: Neurofibromin-deficient Schwann
cells have increased lysophosphatidic acid dependent survival and
migration-implications for increased neurofibroma formation during
pregnancy. Glia 2007;55:527-5362007
27 Cesaretti C, Melloni G, Quagliarini D et al: Neurofibromatosis type 1
and pregnancy: maternal complications and attitudes about prenatal
diagnosis. Am J Med Genet A 2013;161:386-388